Showing results (121-130 of 146) with videos related to
Sort By:
Pageof 15
BMC Medicine|May 19, 2026
Generative AI for spatial tumor growth on MRI: a proof-of-principle study in pediatric diffuse midline gliomaDaria Laslo, Julia Wolleb, Maria Monzon, et al.AJNR. American Journal of Neuroradiology|September 28, 2023
Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular Subtype PredictionJan Lost, Tej Verma, Leon Jekel, et al.The Lancet. Oncology|October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2: challenges, opportunities, and recommendations for clinical translationAnahita Fathi Kazerooni, Ariana M Familiar, Mariam Aboian, et al.The Lancet. Oncology|October 30, 2025
Artificial Intelligence for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 1: review of the current state of the artBenjamin H Kann, Arastoo Vossough, Sarah C Brüningk, et al.AJNR. American Journal of Neuroradiology|December 8, 2025
Focused Ultrasound in Brain Tumors: Mechanisms, Imaging Guidance, and Emerging Clinical ApplicationsAli Nabavizadeh, Kazim Narsinh, Timothy J Kaufmann, et al.Neuro-Oncology|August 30, 2024
Multimodal deep learning improves recurrence risk prediction in pediatric low-grade gliomasMaryamalsadat Mahootiha, Divyanshu Tak, Zezhong Ye, et al.Nature Neuroscience|February 5, 2026
A generalizable foundation model for analysis of human brain MRIDivyanshu Tak, Biniam A Garomsa, Anna Zapaishchykova, et al.AJNR. American Journal of Neuroradiology|February 14, 2025
Imaging Clusters of Pediatric Low-Grade Glioma are Associated with Distinct Molecular CharacteristicsAnahita Fathi Kazerooni, Adam Kraya, Komal S Rathi, et al.International Forum of Allergy & Rhinology|June 27, 2021
Surgical approach is associated with complication rate in sinonasal malignancy: A multicenter studyDaniel M Beswick, Peter H Hwang, Nithin D Adappa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025
Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005Bohyeon Yu, Cassie Kline, Owen Hoare, et al.Pageof 15